| Basics |
AtriCure, Inc.
AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices.
|
| IPO Date: |
August 5, 2005 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.56B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.44 | 2.10%
|
| Avg Daily Range (30 D): |
$0.46 | 1.38%
|
| Avg Daily Range (90 D): |
$0.61 | 1.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.17M |
| Avg Daily Volume (30 D): |
.31M |
| Avg Daily Volume (90 D): |
.44M |
| Trade Size |
| Avg Trade Size (Sh.): |
73 |
| Avg Trade Size (Sh.) (30 D): |
43 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Inst.Trades: |
3,066 |
| Avg Inst. Trade: |
$1.77M |
| Avg Inst. Trade (30 D): |
$2.21M |
| Avg Inst. Trade (90 D): |
$2.38M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2M |
| Avg Closing Trade (30 D): |
$2.53M |
| Avg Closing Trade (90 D): |
$2.77M |
| Avg Closing Volume: |
51.3K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
|
$-.14
|
$-.12
|
|
Diluted EPS
|
|
$-.14
|
$-.12
|
|
Revenue
|
$
|
$ 123.62M
|
$ 7.55M
|
|
Gross Profit
|
$
|
$ 92.63M
|
$
|
|
Net Income / Loss
|
$
|
$ -6.75M
|
$ -23.4M
|
|
Operating Income / Loss
|
$
|
$ -5.95M
|
$ -25.99M
|
|
Cost of Revenue
|
$
|
$ 30.99M
|
$
|
|
Net Cash Flow
|
$
|
$ -22.84M
|
$ 2.72M
|
|
PE Ratio
|
|
|
|
|
|
|
